[144] US Physical Therapy Inc SEC Filing
US Physical Therapy, Inc. (USPH) reported a proposed sale of 1,000 common shares through Rule 144 to be executed on 09/05/2025 on the NYSE via Morgan Stanley Smith Barney LLC. The shares were acquired on 07/01/2024 under the company's Employee Stock Purchase Plan and were paid as compensation. The notice lists an aggregate market value of $85,250.00 for the shares and shows 15,204,119 shares outstanding for the issuer. The filer certifies they are unaware of undisclosed material adverse information and indicates no reportable securities sales in the past three months.
US Physical Therapy, Inc. (USPH) ha segnalato la proposta di vendita di 1.000 azioni ordinarie ai sensi della Rule 144, da eseguirsi il 09/05/2025 sul NYSE tramite Morgan Stanley Smith Barney LLC. Le azioni sono state acquisite il 07/01/2024 nell'ambito dell'Employee Stock Purchase Plan della società e corrisposte come compenso. L'avviso indica un valore di mercato complessivo di $85,250.00 per le azioni e riporta 15,204,119 azioni in circolazione dell'emittente. Il dichiarante certifica di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate e dichiara l'assenza di vendite di titoli rilevanti negli ultimi tre mesi.
US Physical Therapy, Inc. (USPH) informó una propuesta de venta de 1.000 acciones ordinarias bajo la Regla 144, que se ejecutará el 09/05/2025 en la NYSE a través de Morgan Stanley Smith Barney LLC. Las acciones fueron adquiridas el 07/01/2024 en el marco del Employee Stock Purchase Plan de la compañía y fueron pagadas como compensación. El aviso detalla un valor de mercado agregado de $85,250.00 para las acciones y muestra 15,204,119 acciones en circulación del emisor. El declarante certifica no tener conocimiento de información adversa material no divulgada e indica que no ha realizado ventas de valores informables en los últimos tres meses.
US Physical Therapy, Inc. (USPH)는 1,000주 보통주를 Rule 144에 따라 매각할 예정임을 보고했으며, 이는 09/05/2025에 Morgan Stanley Smith Barney LLC를 통해 NYSE에서 실행될 예정입니다. 해당 주식은 회사의 Employee Stock Purchase Plan에 따라 07/01/2024에 취득되었고 보상으로 지급되었습니다. 통지서에는 주식의 총 시가가 $85,250.00로 표시되어 있으며 발행주의 유통 주식 수는 15,204,119주로 기재되어 있습니다. 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 인증하며, 지난 3개월 동안 보고 대상 증권 매각이 없었음을 밝혔습니다.
US Physical Therapy, Inc. (USPH) a signalé la proposition de vente de 1 000 actions ordinaires en vertu de la Rule 144, à exécuter le 09/05/2025 sur le NYSE via Morgan Stanley Smith Barney LLC. Les actions ont été acquises le 07/01/2024 dans le cadre du Employee Stock Purchase Plan de la société et ont été rémunérées en tant que compensation. L'avis indique une valeur de marché agrégée de $85,250.00 pour les actions et fait état de 15,204,119 actions en circulation de l'émetteur. Le déclarant certifie ne pas être au courant d'informations défavorables matérielles non divulguées et indique n'avoir réalisé aucune vente de titres à déclarer au cours des trois derniers mois.
US Physical Therapy, Inc. (USPH) meldete einen geplanten Verkauf von 1.000 Stammaktien gemäß Rule 144, der am 09/05/2025 an der NYSE über Morgan Stanley Smith Barney LLC ausgeführt werden soll. Die Aktien wurden am 07/01/2024 im Rahmen des Employee Stock Purchase Plan des Unternehmens erworben und als Vergütung ausgezahlt. Die Mitteilung nennt einen aggregierten Marktwert von $85,250.00 für die Aktien und weist 15,204,119 ausstehende Aktien des Emittenten aus. Der Einreicher bestätigt, keine nicht offengelegten, wesentlichen nachteiligen Informationen zu kennen, und gibt an, in den letzten drei Monaten keine meldepflichtigen Wertpapierverkäufe getätigt zu haben.
- Clear compliance with Rule 144 disclosure requirements including acquisition details and broker information
- No sales by the filer in the prior three months, suggesting this is not part of a larger unwind
- None materially indicated in the filing; transaction size is immaterial to company capitalization
Insights
TL;DR: Small Rule 144 sale of ESPP shares; immaterial to company value but relevant for insider liquidity tracking.
The filing shows an individual selling 1,000 shares acquired via an ESPP, scheduled for sale on the NYSE through a major brokerage. Given the aggregate value of $85,250 versus 15.2 million shares outstanding, this transaction is immaterial to USPH's capitalization and operating performance. The absence of other sales in the past three months and the filer's representation about public disclosure reduce immediate governance concerns. This is a routine insider liquidity event rather than a signal of company-level stress.
TL;DR: Compliance-focused disclosure consistent with Rule 144; no red flags in the notice.
The notice provides required details: acquisition date, nature of acquisition (ESPP), payment type (compensation), broker identity, and planned sale date. The filer affirms no undisclosed material information and reports no recent sales, which aligns with standard compliance practice for insiders selling restricted or control securities. From a governance perspective, this is a routine, properly documented sale under the securities rules.
US Physical Therapy, Inc. (USPH) ha segnalato la proposta di vendita di 1.000 azioni ordinarie ai sensi della Rule 144, da eseguirsi il 09/05/2025 sul NYSE tramite Morgan Stanley Smith Barney LLC. Le azioni sono state acquisite il 07/01/2024 nell'ambito dell'Employee Stock Purchase Plan della società e corrisposte come compenso. L'avviso indica un valore di mercato complessivo di $85,250.00 per le azioni e riporta 15,204,119 azioni in circolazione dell'emittente. Il dichiarante certifica di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate e dichiara l'assenza di vendite di titoli rilevanti negli ultimi tre mesi.
US Physical Therapy, Inc. (USPH) informó una propuesta de venta de 1.000 acciones ordinarias bajo la Regla 144, que se ejecutará el 09/05/2025 en la NYSE a través de Morgan Stanley Smith Barney LLC. Las acciones fueron adquiridas el 07/01/2024 en el marco del Employee Stock Purchase Plan de la compañía y fueron pagadas como compensación. El aviso detalla un valor de mercado agregado de $85,250.00 para las acciones y muestra 15,204,119 acciones en circulación del emisor. El declarante certifica no tener conocimiento de información adversa material no divulgada e indica que no ha realizado ventas de valores informables en los últimos tres meses.
US Physical Therapy, Inc. (USPH)는 1,000주 보통주를 Rule 144에 따라 매각할 예정임을 보고했으며, 이는 09/05/2025에 Morgan Stanley Smith Barney LLC를 통해 NYSE에서 실행될 예정입니다. 해당 주식은 회사의 Employee Stock Purchase Plan에 따라 07/01/2024에 취득되었고 보상으로 지급되었습니다. 통지서에는 주식의 총 시가가 $85,250.00로 표시되어 있으며 발행주의 유통 주식 수는 15,204,119주로 기재되어 있습니다. 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 인증하며, 지난 3개월 동안 보고 대상 증권 매각이 없었음을 밝혔습니다.
US Physical Therapy, Inc. (USPH) a signalé la proposition de vente de 1 000 actions ordinaires en vertu de la Rule 144, à exécuter le 09/05/2025 sur le NYSE via Morgan Stanley Smith Barney LLC. Les actions ont été acquises le 07/01/2024 dans le cadre du Employee Stock Purchase Plan de la société et ont été rémunérées en tant que compensation. L'avis indique une valeur de marché agrégée de $85,250.00 pour les actions et fait état de 15,204,119 actions en circulation de l'émetteur. Le déclarant certifie ne pas être au courant d'informations défavorables matérielles non divulguées et indique n'avoir réalisé aucune vente de titres à déclarer au cours des trois derniers mois.
US Physical Therapy, Inc. (USPH) meldete einen geplanten Verkauf von 1.000 Stammaktien gemäß Rule 144, der am 09/05/2025 an der NYSE über Morgan Stanley Smith Barney LLC ausgeführt werden soll. Die Aktien wurden am 07/01/2024 im Rahmen des Employee Stock Purchase Plan des Unternehmens erworben und als Vergütung ausgezahlt. Die Mitteilung nennt einen aggregierten Marktwert von $85,250.00 für die Aktien und weist 15,204,119 ausstehende Aktien des Emittenten aus. Der Einreicher bestätigt, keine nicht offengelegten, wesentlichen nachteiligen Informationen zu kennen, und gibt an, in den letzten drei Monaten keine meldepflichtigen Wertpapierverkäufe getätigt zu haben.